They have been stating that they needed money for trialing to be able to submit for FDA approval. None of their financials show any funds ever going for trialing. EVER. Only for toxic debt. That is why the shares went from 156 million to possibly over TWO BILLION in the past year!
Convertible Loan Note debt has been applied for, providing a claim on 330 million reserved Common Stock shares at par value
Total shares outstanding: Common shares 1,184,894,145 09/30/2014
Convertible Loan Note debt has been applied for, providing a claim on 330 million reserved Common Stock shares at par value
Plus 117,500,000 ISSUED TO Blackbridge Capital, LLC
BASED ON THE ABOVE, MINIMUM O/S SHOULD BE 1,632,394,145 A/O 12/8/2014